CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
Jun. 30, 2016 |
Jun. 30, 2015 |
|
| Condensed Statements Of Income And Comprehensive Income | ||||
| REVENUE | $ 20,447,000 | $ 1,747,000 | $ 25,637,000 | $ 7,374,000 |
| OPERATING EXPENSES: | ||||
| Costs of revenue | 5,754,000 | 478,000 | 7,240,000 | 2,167,000 |
| Professional fees and related costs | 372,000 | 327,000 | 825,000 | 773,000 |
| General and administrative | 426,000 | 792,000 | 828,000 | 1,451,000 |
| Amortization of patents | 297,000 | 413,000 | 711,000 | 826,000 |
| Stock-based compensation | 32,000 | 74,000 | 44,000 | 174,000 |
| Contingent patent cost | 500,000 | 500,000 | ||
| TOTAL OPERATING EXPENSES | 7,381,000 | 2,084,000 | 10,148,000 | 5,391,000 |
| OPERATING INCOME (LOSS) | 13,066,000 | (337,000) | 15,489,000 | 1,983,000 |
| OTHER INCOME: | ||||
| Interest income, net | 16,000 | 12,000 | 26,000 | 33,000 |
| INCOME (LOSS) BEFORE INCOME TAXES (BENEFIT) | 13,082,000 | (325,000) | 15,515,000 | 2,016,000 |
| INCOME TAXES (BENEFIT): | ||||
| Current | 330,000 | (15,000) | 381,000 | 40,000 |
| Deferred taxes (benefit), net | 4,522,000 | (90,000) | 3,084,000 | 666,000 |
| Total income taxes (benefit) | 4,852,000 | (105,000) | 3,465,000 | 706,000 |
| NET INCOME (LOSS) | $ 8,230,000 | $ (220,000) | $ 12,050,000 | $ 1,310,000 |
| Net Income (Loss) Per Share | ||||
| Basic | $ 0.35 | $ (0.01) | $ 0.52 | $ 0.06 |
| Diluted | $ 0.33 | $ (0.01) | $ 0.49 | $ 0.05 |
| Weighted average common shares outstanding: | ||||
| Basic | 23,300,638 | 23,439,468 | 23,276,295 | 23,761,420 |
| Diluted | 24,637,316 | 23,439,468 | 24,451,944 | 25,006,281 |
| NET INCOME (LOSS) | $ 8,230,000 | $ (220,000) | $ 12,050,000 | $ 1,310,000 |
| OTHER COMPREHENSIVE INCOME (LOSS): | ||||
| Unrealized holding gain (loss) on securities available-for-sale arising during the period | 16,000 | (32,000) | 43,000 | (12,000) |
| COMPREHENSIVE INCOME (LOSS) | $ 8,246,000 | $ (252,000) | $ 12,093,000 | $ 1,298,000 |
| X | ||||||||||
- Definition custom:ContingentPatentCost No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net amount of operating interest income (expense). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Revenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|